Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Morgan Stanley 21^st Annual Global Healthcare Conference at the Sheraton New York Hotel in New York on Wednesday, September 13^th. Joaquin Duato, Chairman of the Board and Chief Executive Officer and John Reed, Executive Vice President Pharmaceuticals R&D will represent the Company in a session scheduled at 10:10 a.m. (Eastern Time).

This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately 48 hours after the live webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230822087768/en/